You are here

Article info

Article menu
XML
Clinical science
Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration

Authors

  1. Correspondence to Yoko Ozawa, Laboratory of Retinal Cell Biology, Department of Ophthalmology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; ozawa{at}a5.keio.jp
View Full Text

Citation

Suzuki M, Nagai N, Izumi-Nagai K, et al
Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration
British Journal of Ophthalmology 2014;98:1186-1191.

Publication history

  • Received November 21, 2013
  • Revised February 24, 2014
  • Accepted March 20, 2014
  • First published April 7, 2014.
Online issue publication 
March 22, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/